Investors now have three ASX-listed stem cell therapy companies to choose from – and we can thank sector big daddy Mesoblast ...

Tumor microenvironment (TME) plays a pivotal role in malignant progression and metastatization in several tumors, including ...

Stem cells sound vaguely futuristic but they are increasingly being used in a wide range of medical applications. Their ...

Stem cell injections, platelet rich plasma and ivermectin do big business despite dubious or no evidence supporting their use in rheumatology. However, far from being a recent development, this type ...

Mesoblast's RYONCIL ® (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months and older is the first FDA approved mesenchymal ...

Fritz Lipmann Institute (FLI) in Jena have discovered a previously unknown function of immune cells in the bone marrow.

What if we could reprogramme the TME itself? Cutting-edge research suggests that engineered mesenchymal stem cells (MSCs) ...